AktieBiotechnologie

INTRA-CELLULAR THERAPIES

WKN
A1XDTL
ISIN
US46116X1019
Ticker
ITCI
23I
WKN
A1XDTL
Ticker
ITCI
23I
ISIN
US46116X1019
Nasdaq
131,870 USD
-0,050 USD-0,04 %
Geld
131,900 USD
(4.900 Stk.)
Brief
131,920 USD
(19.800 Stk.)

Unternehmens­daten

Stammdaten zu INTRA-CELLULAR THERAPIES

WKN
A1XDTL
ISIN
US46116X1019
Home-Symbol
ITCI
Symbol
23I
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Unbekannt
Land

Marktdaten

Marktkapitalisierung
Anzahl Aktien
Streubesitz

Alle Aktien des Unternehmens

Anteilseigner

The Vanguard Group, Inc.BlackRock Fund AdvisorsAlafi Capital Co. LLCJPMorgan Investment Management, Inc.Wasatch Advisors LPNorges Bank Investment ManagementAvoro Capital Advisor LLCInvesco Advisers, Inc.Fidelity Management & Research Co. LLCBellevue Asset Management AGDeep Track Capital LPSSgA Funds Management, Inc.Geode Capital Management LLCClearBridge Investments LLCPictet Asset Management SAFranklin Advisers, Inc.Suvretta Capital Management LLCGW&K Investment Management LLCPerceptive Advisors LLCWestfield Capital Management Co. LP
  • The Vanguard Group, Inc. (8,99 %)
  • BlackRock Fund Advisors (5,01 %)
  • Alafi Capital Co. LLC (4,46 %)
  • JPMorgan Investment Management, Inc. (4,15 %)
  • Wasatch Advisors LP (3,06 %)
  • Norges Bank Investment Management (3,02 %)
  • Avoro Capital Advisor LLC (2,87 %)
  • Invesco Advisers, Inc. (2,76 %)
  • Fidelity Management & Research Co. LLC (2,53 %)
  • Bellevue Asset Management AG (2,30 %)

Kontakt